ASPM and hepatocellular carcinoma: Conversely, patients with HCC in the low expression groups of ASPM, BUB1B, CCNA2, CCNB1, CDC20, KIF11, MAD2L1, and TOP2A demonstrated significantly better OS than those in the high expression groups (all p < 0.05) (Figure 8).